Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

The document concludes that more research is needed to fully understand the causes of PCOS.

Certain extracts from Curcuma aeruginosa Roxb. and germacrone can boost the skin's absorption of minoxidil, a hair growth promoter, making it more effective.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Alternative treatments show promise for hair growth beyond traditional methods.

More body hair in young Australian women is linked to higher androstenedione levels.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

The free androgen index varies among women with different types of PCOS.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Acne in dark skin is influenced by environmental factors and can lead to hyperpigmentation, with various treatment options available.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

Reducing granulosa cell pyroptosis may improve oocyte maturation in PCOS.